CompletedNCT04276259
Reward Learning and Rapid Improvement in Depression
About this title
Read the official source — NCT04276259Medication studyAges 18–55United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: October 19, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 120
- Sponsor
- Marta Peciña, MD PhD
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Device, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT04276259
- Official title
Show the full official title
Neurocomputational Mechanisms of Mood Improvement
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Marta Peciña, MD PhD.
Did this study involve medication?
Yes. The study involved medication, including Buprenorphine, Naltrexone, Oral Placebo and IM Placebo.
Who was this study for?
Listed age limits: 18 years to 55 years.
